Michael Byrnes is Chief Financial Officer of eFFECTOR Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CERO THERAPEUTICS HOLDINGS, INC.
27 Mar 24
4
eFFECTOR Therapeutics, Inc.
21 Feb 24
3
CERO THERAPEUTICS HOLDINGS, INC.
16 Feb 24
4
eFFECTOR Therapeutics, Inc.
16 Nov 23
4
eFFECTOR Therapeutics, Inc.
16 May 23
4
eFFECTOR Therapeutics, Inc.
19 Jan 23
4
eFFECTOR Therapeutics, Inc.
16 Nov 22
4
eFFECTOR Therapeutics, Inc.
22 Jun 22
4
eFFECTOR Therapeutics, Inc.
7 Jun 22
4
eFFECTOR Therapeutics, Inc.
17 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | CERO Phoenix Biotech Acquisition | Stock Option Common Stock | Grant | Acquire A | No | No | 1.77 | 112,500 | 199.13 k | 112,500 |
15 Nov 23 | EFTR eFFECTOR Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.4973 | 4,524 | 2.25 k | 43,271 |
15 May 23 | EFTR eFFECTOR Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.459 | 4,863 | 2.23 k | 38,747 |
17 Jan 23 | EFTR eFFECTOR Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.47 | 500,000 | 235.00 k | 500,000 |